ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 145 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,137,150 | +17246.4% | 635,000 | -66.2% | 0.78% | -82.5% |
| Q4 2022 | $29,615 | -99.9% | 1,880,286 | -22.0% | 4.46% | -26.8% |
| Q3 2022 | $37,943,000 | +12.8% | 2,410,622 | 0.0% | 6.10% | -14.3% |
| Q2 2022 | $33,652,000 | -15.7% | 2,410,622 | +4.1% | 7.12% | -20.2% |
| Q1 2022 | $39,905,000 | +2.7% | 2,314,648 | -13.4% | 8.91% | -1.0% |
| Q4 2021 | $38,856,000 | -1.4% | 2,672,346 | +22.0% | 9.00% | -13.4% |
| Q3 2021 | $39,425,000 | +34.5% | 2,190,291 | +31.2% | 10.39% | +1.8% |
| Q2 2021 | $29,307,000 | +13.1% | 1,668,987 | +62.3% | 10.21% | -1.1% |
| Q1 2021 | $25,908,000 | +199.7% | 1,028,084 | -23.1% | 10.32% | +119.5% |
| Q4 2020 | $8,646,000 | – | 1,336,275 | – | 4.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 441,000 | $833,000 | 2.78% |
| MFN Partners Management, LP | 4,000,000 | $7,560,000 | 1.56% |
| Endurant Capital Management LP | 2,055,069 | $3,884,000 | 1.22% |
| Broadfin Capital, LLC | 1,888,039 | $3,568,000 | 0.48% |
| Aisling Capital Management LP | 634,455 | $1,199,000 | 0.46% |
| EcoR1 Capital, LLC | 2,087,312 | $3,945,000 | 0.36% |
| Sofinnova Investments, Inc. | 1,911,573 | $3,613,000 | 0.26% |
| Alambic Investment Management, L.P. | 115,036 | $217,000 | 0.18% |
| Parkman Healthcare Partners LLC | 225,000 | $425,000 | 0.12% |
| Rock Springs Capital Management LP | 1,600,000 | $3,024,000 | 0.10% |